Abstract
Introduction
The rapid expansion of mobile phone access has enabled low-cost SMS interventions to support adherence to antiretroviral therapy (ART). Although text messaging improves adherence and retention in HIV care, its cost-effectiveness for enhancing quality of life remains uncertain, particularly among adolescents in resource-limited settings. This study evaluated whether SMS reminders improve retention in care and quality-adjusted life years (QALYs) among adolescents living with HIV in Ethiopia. We hypothesized that SMS reminders would increase adherence and retention, leading to measurable gains in quality of life.
Methods
A 6-month economic evaluation was conducted from the health system perspective, comparing daily SMS reminders plus standard care vs. standard care alone. HRQoL was measured using the EuroQol EQ-5D-3L instrument, which includes five domains: mobility, self-care, usual activity, pain/discomfort, and anxiety/depression. Utility values were derived using the Zimbabwean EQ-5D-3L value set as a proxy for Ethiopia and converted into QALYs. Costs were categorized as fixed (planning, system development, training) and variable (personnel, SMS communication, equipment, and overhead), valued in 2023 US dollars (USD; 1 USD = 54.7442 ETB). The Incremental Cost-Effectiveness Ratio (ICER) was calculated as ΔCost/ΔQALY. The WHO-CHOICE cost-effectiveness threshold (<3 × GDP per capita; $3,636 for Ethiopia, 2023) guided interpretation.
Results
Daily SMS reminders were cost-effective according to WHO thresholds, with an ICER of $1,037.00 per QALY gained. Accounting for potential retention improvements, the ICER decreased to $864.00 per QALY gained. Intervention participants had higher utility scores (0.9515 vs. 0.9030) and QALYs (0.4760 vs. 0.4510) compared to controls.
Discussion
SMS-based adherence interventions offer a cost-efficient approach to improving ART outcomes by enhancing adherence and retention. Anxiety/depression and pain/discomfort were key determinants of QALYs. Future research should assess long-term cost-effectiveness and scalability in resource-limited settings.
Trial Registration
PACTR202107638293593.
Keywords: adolescents, antiretroviral therapy, cost-effectiveness, EQ-5D-3L, HIV, QALYs, quality-adjusted life years, SMS
Introduction
Quality of life (QoL) refers to an individual's overall physical, psychological, and social wellbeing as perceived within the context of their health condition (1). In health economics, QoL is often expressed through the concept of quality-adjusted life years (QALYs), which combine both the quantity and quality of life lived into a single standardized measure (2). QALYs are widely recognized as the principal metric in economic evaluations because they enable comparisons across different interventions and disease conditions, supporting evidence-informed decision-making in health policy (3). Unlike clinical outcomes that primarily reflect physiological or symptomatic improvements, QALYs incorporate patient-centered perspectives and health-related wellbeing, offering a more comprehensive evaluation of intervention benefits (4).
Adolescents living with HIV (ALHIV) experience multiple challenges such as stigma, treatment fatigue, limited autonomy, and psychosocial stress that negatively impact adherence to antiretroviral therapy (ART) and, consequently, their QoL and treatment outcomes (5, 6). Although ART has transformed HIV infection into a manageable chronic condition, allowing individuals to achieve near-normal life expectancy (7), maintaining adherence remains a persistent problem among adolescents, particularly in sub-Saharan Africa (SSA) (8, 9).
Mobile health (mHealth) interventions, such as SMS reminders and mobile app–based adherence support, have been increasingly applied to enhance treatment adherence and health outcomes in chronic diseases, including HIV (10). Evidence from global systematic reviews demonstrates that mHealth interventions can significantly improve ART adherence and viral suppression rates (11, 12). In low- and middle-income countries (LMICs), and particularly in SSA, studies have shown that SMS-based reminders are effective in supporting medication adherence and retention in care among adults living with HIV (13–15). However, the evidence for their impact among adolescents remains limited, and few studies have examined their cost-effectiveness (16, 17).
Ethiopia has achieved substantial ART scale-up over the past two decades, rising from around 4% coverage in 2005/6 to nearly 98% of diagnosed people living with HIV on treatment by 2022 (9). Despite this progress, adolescents aged 15–19 years continue to lag behind adults in ART initiation, adherence, and viral suppression (18, 19), highlighting a critical gap that must be addressed to meet national and global HIV targets. Moreover, the integration of QALY-based evaluation within adolescent HIV research is scarce, limiting understanding of the broader health and economic benefits of digital adherence support. Therefore, this study aimed to evaluate the effect of an SMS-based adherence intervention on QALYs among adolescents living with HIV in Ethiopia.
Methods and materials
Setting and study period
The study was conducted from 5 July 2022 to 28 February 2023 in six hospitals and five health centers providing HIV care to adolescents across five zones of South Ethiopia. Hospitals with comprehensive adolescent HIV services were purposively selected, and all eligible facilities were included to ensure complete coverage.
Study population
All eligible adolescents in both the intervention and control arms (n = 306, 1:1 ratio) were provided with mobile phones to ensure uniform access to communication with healthcare providers. However, only participants in the intervention arm received SMS reminders as part of the adherence support intervention.
Control arm participants received only standard care per national guidelines (20), including clinical assessment, index case testing, mental health and nutritional support, sexual and reproductive health, psychosocial support, community care, youth-friendly services, and transition to adult care. Additionally, all adolescents received a mobile phone for communication with healthcare providers. Follow-up data and blood samples were collected at each visit.
Ethics statement
The study was conducted in accordance with the Declaration of Helsinki and received ethical approval from the Swedish Regional Ethical Review Board (Reg. no. 2019-03433), the National Research Ethics Review Committee, Ethiopia (MoSHE/RD/142/2869/20), and the Institutional Research Ethics Review Board at Arba Minch University (IRB-113/11). Permission to collect data was obtained from the administration of each participating hospital and health center. For participants aged 10–17 years, written informed consent was obtained from parents or guardians, along with assent from the adolescents, including permission to access their medical records. Participants aged ≥18 years provided written informed consent themselves.
Socio-demographic and healthcare-related characteristics
Data on socio-demographic and healthcare-related characteristics were collected to describe the study population and account for potential confounders. Socio-demographic variables included age, sex, residence (urban/rural), education, marital status, and living arrangement (with family or alone). Healthcare-related variables comprised type of health facility (hospital or health center), duration on ART, and mode of ART delivery. Information was obtained using a structured questionnaire and verified against medical records. Data collection occurred at baseline (Visit 1), midline at 3 months (Visit 2), and endline at 6 months (Visit 3) using the mobile version of REDCap (21).
Health outcomes measurement
Health-related quality of life (HRQoL) was measured using the EuroQol EQ-5D-3L instrument (22), which includes five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. In contrast, the EQ-5D-5L lacks local validation and established value sets in Ethiopia, which limits comparability and interoperability for economic evaluation in this context.
Participants rated their health status in each domain on three levels: no problems, some problems, or extreme problems. For analysis, responses were dichotomized as “no problem” (0) and “has problems” (1), with levels 2 and 3 recoded as “has problems” to represent functionality status. These domains are used to derive utility values for QALY calculation. Responses obtained from the EQ-5D-3L instrument were changed into an index value, which in turn was converted to QALY or utility scores using country-specific value sets. Since an Ethiopian EQ-5D tariff has not yet been developed, we used the Zimbabwean EQ-5D-3L value set that has been widely used in sub-Saharan Africa due to its similar cultural and socio-economic context (22). The index values were converted into utility scores by applying the standard EQ-5D valuation methodology, where each health state described by the five EQ-5D dimensions is assigned a weight derived from population preferences elicited through TTO techniques (23, 24). Utility values range from 1 (perfect health) to 0 (death), whereas utility scores below 0 represent health states considered worse than death (25).
Cost categories
We classified cost data into fixed and variable costs. Fixed costs encompassed activities such as intervention planning, site preparation, development of the mobile SMS text messaging management system, and initial training. Variable costs covered recurring expenses necessary to maintain the intervention, categorized into distinct input groups: personnel, communication, equipment, and overhead. Personnel costs included salaries, benefits, and allowances for facility-based health workers, as well as staff responsible for supervision and coordination. Communication costs encompassed cloud hosting of solution platform fees, internet data bundles for the Mobile system, and SMS messaging expenses. Equipment included mobile phones, desktops, and routers. All costs were converted to 2023 US dollars using the average ETB–USD exchange rate (1 USD = 54.7442 ETB; National Bank of Ethiopia, 2023) to reflect the economic context closest to the study period and enable comparison with the WHO-CHOICE cost-effectiveness threshold (26). Research-related expenses, including research time as well as supervisors' travel and accommodation costs, were excluded to ensure the analysis reflected the actual program costs when implemented and scaled locally.
Data analysis
Data were compiled and analyzed using Microsoft Excel 2019 (Microsoft Office 365) to estimate total and incremental costs, as well as incremental cost-effectiveness ratios (ICERs). Study data were initially collected in REDCap and subsequently exported to Excel for analysis. Two trained research assistants independently entered all data and performed double-checks to ensure accuracy. Comparisons between the intervention and control groups were conducted using appropriate statistical tests. All tests were two-sided with a significance level of 0.05, and 95% confidence intervals (CIs) were reported to quantify the precision of estimates, including differences in QALYs, utility scores, and adherence outcomes.
ICERs were calculated as the ratio of incremental cost to incremental QALYs gained:
Costs were assessed from the health system perspective and categorized as fixed (planning, system development, training, equipment) and variable (personnel, SMS communication, office supplies, overhead). Resource use was measured based on actual data, with each unit multiplied by its respective cost (Supplementary Table S1). All costs were converted to 2023 US dollars using the average ETB–USD exchange rate (1 USD = 54.7442 ETB; National Bank of Ethiopia, 2023). The incremental cost represents the additional resources required to deliver the SMS intervention compared to standard care.
Results
Socio-demographic and healthcare-related characteristics
A total of 306 adolescents living with HIV were included in the analysis, with equal distribution between the intervention group (n = 153) and the control group (n = 153). Most participants (61.4%) were aged 15–19 years (intervention: 60.8%; control: 62.1%), and 56.2% were male (intervention: 50.9%; control: 61.4%). The majority resided in urban areas (73.2%) and were students (94.4%). Regarding healthcare access, 248 participants (81%) received services from hospitals, while the remaining 19% attended health centers. Nearly all adolescents (97.1%) were unmarried, and most (93.8%) lived with their family; only a small proportion lived alone (6.2%). These distributions were similar across both study arms.
Functionality status by EQ-5D-3L dimensions
The proportion of adolescents reporting problems in each EQ-5D-3L dimension is presented in Figure 1. At Visit 2, 29% of participants in the control group reported problems with Pain/Discomfort, compared to 18% in the intervention group (χ2 = 4.65, df = 1, p = 0.031), indicating a higher proportion of reported problems in the control arm. No significant differences were observed in the other dimensions at this time point (all p > 0.05).
Figure 1.
Health problems reported in EQ-5D health dimensions among adolescents living with HIV in South Ethiopia, 2024.
Over the 6-month period, the intervention group demonstrated improvements in self-care, usual activity, and anxiety/depression compared to the control group. Anxiety/depression decreased from 24% at Visit 1 to 12% at Visit 3 in the intervention group, whereas the control group showed a slight increase from 30 to 31% (χ2 = 6.28, df = 1, p = 0.012). These findings indicate that adolescents in the intervention group reported fewer problems in key EQ-5D-3L dimensions over the study period, which are dimensions relevant to health-related quality of life and QALYs.
EQ-5D-3L utility scores
Mean utility scores and QALYs for each study arm are summarized in Table 1. Over 6 months, participants in the intervention group had higher mean utility scores compared to the control group (0.9206 ± 0.2010 vs. 0.8963 ± 0.2400; t = 2.48, df = 914, p = 0.013). The mean QALYs were also higher in the intervention group (0.4760 ± 0.1040) than in the control group (0.4510 ± 0.1200), with a mean difference of 0.0250 (95% CI: 0.0123–0.0363), reflecting a clinically meaningful improvement consistent with the Minimal Clinically Important Difference (MCID) for EQ-5D-3L (0.03–0.07) (27).
Table 1.
EQ-5D-3L utility scores of adolescents living with HIV, South Ethiopia, 2023.
| Time of measurement | Intervention arm (n = 153) | Control arm (n = 153) | ||
|---|---|---|---|---|
| Mean utilities (SD) | Mean QALY (SD) | Mean utilities (SD) | Mean QALYs (SD) | |
| Baseline (visit 1) | 0.9222 (0.20) | 0.4611 (0.10) | 0.9031 (0.22) | 0.4515 (0.11)* |
| 3rd month (visit 2) | 0.9274 (0.18) | 0.4637 (0.09) | 0.8903 (0.24) | 0.4451 (0.12) |
| 6th month (visit 3) | 0.9122 (0.22) | 0.4561 (0.11)* | 0 0.8955 (0.25) | 0.4478 (0.12) |
| Overall | 0.9206 (0.20) | 0.4603 (0.10) | 0.8963 (0.24) | 0.4481 (0.12) |
SD, standard deviation.
n = 152 due to one participant lost to follow-up at 6 months.
**n = 151 due to two participant lost to follow-up at baseline.
Missing data
Three participants in the intervention group and two in the control group were lost to follow-up by Month 6. Analyses were conducted using complete cases; sensitivity analyses including last observation carried forward yielded consistent results (Table 2).
Table 2.
Quality-adjusted life years of adolescents living with HIV over a 6-month follow-up, South Ethiopia, 2023.
| Study arm | Observed | Mean | Std.err | Std.dev. | 95% CI | |
|---|---|---|---|---|---|---|
| Intervention arm | 458 | 0.475 | 0.003 | 0.070 | 0.469 | 0.482 |
| Standard of care arm | 457 | 0.451 | 0.005 | 0.108 | 0.441 | 0.461 |
| Difference | 0.024 | 0.006 | 0.012 | 0.036 | ||
Std. err., standard error; Std. dev., standard deviation; 95% CI, 95% confidence interval.
The mean QALYs for adolescents over the present study's 6-month period was 0.4637, with a standard error of 0.02. The lower QALY score may suggest a decrease in life expectancy, a lower quality of life, or a mix of both. Adolescents who received reminder text messages had a mean QALY of 0.476 with a standard error of 0.003, compared to 0.451 with a standard error of 0.005 in the control group. Adolescents living with HIV often experience reduced QALY scores due to challenges such as chronic disease management, stigma, and psychosocial issues.
Discussion
This study is the first to provide empirical evidence on health state utility values among adolescents living with HIV in Ethiopia using the EQ-5D-3L instrument. The findings demonstrate that adolescents in the intervention arm experienced notable improvements in self-care, usual activities, and anxiety/depression compared to the standard-of-care group. The observed improvement in mental health among adolescents in the intervention arm is consistent with previous studies showing that integrated psychosocial support can reduce anxiety and depressive symptoms. Additionally, improvements were observed in functional domains, with a substantial reduction in self-care difficulties and a modest decline in limitations in usual activities, suggesting broader benefits of the intervention on daily functioning over time. These benefits are likely mediated through improved self-efficacy, reduced treatment-related stress, and strengthened patient–provider communication (6, 28).
The mean utility score was higher in the intervention group (0.9206, SD: 0.201) than in the control group (0.8963, SD: 0.240), indicating a clinically meaningful difference in perceived health status. Adolescents in the intervention group experienced an average improvement of 4.8 percentage points in HRQoL, reflecting the intervention's positive effect. These results are consistent with studies from SSA showing that supportive counseling and digital health interventions improve adherence and mental wellbeing among adolescents living with HIV (11, 15, 22, 29, 30). A study in Kenya reported that structured psychosocial support significantly improved EQ-5D-based HRQoL scores among youth receiving ART (31). Similarly, research in South Africa and Uganda found that reducing anxiety and depression symptoms was associated with improved adherence and viral suppression, which translated into higher QALYs (32–34).
Our findings are consistent with earlier evidence showing that depression and anxiety are key determinants of HRQoL among people living with HIV (35). Improvements in psychological wellbeing have important implications beyond clinical outcomes, as mental health is a key contributor to health-related quality of life and QALY gains. The observed reduction in anxiety and depression may therefore partly explain the higher utility scores and QALYs observed in the intervention arm.
The study has several strengths. It was conducted across multiple hospitals and health centers in both urban and rural settings and included a relatively large cohort of adolescents. To our knowledge, this is the first study in Ethiopia to estimate EQ-5D-3L utility values among adolescents living with HIV, providing a baseline reference for future cost-utility analyses and intervention evaluations. However, some limitations should be acknowledged. The EQ-5D-3L may have limited sensitivity to small changes in HRQoL, and self-reported data may be subject to social desirability bias. Additionally, the absence of a locally derived value set may slightly affect utility precision.
Conclusion
This study evaluated the effect of SMS-based adherence support on quality-adjusted life years (QALYs) among adolescents living with HIV in Ethiopia. The intervention significantly improved HRQoL, particularly by reducing anxiety and depression and enhancing self-care and daily functioning, compared to standard care. These findings demonstrate that low-cost digital adherence interventions can effectively improve both mental health and overall health outcomes in this population. The utility values derived provide a valuable reference for future economic evaluations and support the integration of psychosocially informed digital interventions into adolescent HIV care in resource-limited settings.
Acknowledgments
The authors thank the study participants and their caregivers for their time and trust. We are also grateful to the data collectors, health professionals, and facility managers who facilitated the research process.
Funding Statement
The author(s) declared that financial support was received for this work and/or its publication. The study was funded by the Swedish Research Council for Health, Working Life and Welfare (FORTE, program support 2018-01399; https://forte.se/en/) and the Swedish Research Council (VR, program support 2016-05706; https://www.vr.se/english.html). The study protocol underwent peer review by the funding bodies. The funders had no role in the study design, writing of the protocol, decision to publish, or preparation of this manuscript.
Edited by: Shameer Khader, Sanofi, France
Reviewed by: Julie Abimanyi-Ochom, Deakin University, Australia
Assis Kamu, Universiti Malaysia Sabah, Malaysia
Abbreviations: ALHIV, adolescents living with HIV; ART, antiretroviral therapy; EQ-5D-3L, EuroQol five dimensions three level instrument; HRQoL, health-related quality of life; ICER, incremental cost-effectiveness ratio; IVR, interactive voice response; QALY, quality-adjusted life year; SMS, short message service.
Data availability statement
The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.
Ethics statement
The studies involving humans were approved by Swedish Regional Ethical Review Board (Reg. no. 2019-03433), National Research Ethics Review Committee in Ethiopia (MoSHE/RD/142/2869/20), and the Institutional Research Ethics Review Board at Arba Minch University (IRB-113/11). The studies were conducted in accordance with the local legislation and institutional requirements. Written informed consent for participation in this study was provided by the participants' legal guardians/next of kin.
Author contributions
AT: Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Writing – review & editing. PL: Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Writing – review & editing. MP: Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Writing – review & editing. GK: Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Writing – review & editing. RV: Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Writing – review & editing. DJ: Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Writing – review & editing.
Conflict of interest
The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Generative AI statement
The author(s) declared that generative AI was not used in the creation of this manuscript.
Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fpubh.2026.1718940/full#supplementary-material
References
- 1.Group TW. The world health organization quality of life assessment (WHOQOL): development and general psychometric properties. Soc Sci Med. (1998) 46:1569–85. doi: 10.1016/S0277-9536(98)00009-4 [DOI] [PubMed] [Google Scholar]
- 2.Claxton K. Methods for the Economic Evaluation of Health Care Programmes. (1987). Oxford. [Google Scholar]
- 3.Gold MR. Cost-Effectiveness in Health and Medicine. New York, NY: Oxford University Press; (1996). doi: 10.1093/oso/9780195108248.001.0001 [DOI] [Google Scholar]
- 4.Weinstein MC, Stason WB. Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med. (1977) 296:716–21. doi: 10.1056/NEJM197703312961304 [DOI] [PubMed] [Google Scholar]
- 5.Bernays S, Paparini S, Seeley J, Rhodes T. “Not taking it will just be like a sin”: young people living with HIV and the stigmatization of less-than-perfect adherence to antiretroviral therapy. Med Anthropol. (2017) 36:485–99. doi: 10.1080/01459740.2017.1306856 [DOI] [PubMed] [Google Scholar]
- 6.Kim S-H, Gerver SM, Fidler S, Ward H. Adherence to antiretroviral therapy in adolescents living with HIV: systematic review and meta-analysis. AIDS. (2014) 28:1945–56. doi: 10.1097/QAD.0000000000000316 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Mills EJ, Bakanda C, Birungi J, Chan K, Ford N, Cooper CL, et al. Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda. Ann Intern Med. (2011) 155:209–16. doi: 10.7326/0003-4819-155-4-201108160-00358 [DOI] [PubMed] [Google Scholar]
- 8.Adejumo OA, Malee KM, Ryscavage P, Hunter SJ, Taiwo BO. Contemporary issues on the epidemiology and antiretroviral adherence of HIV-infected adolescents in sub-Saharan Africa: a narrative review. J Int AIDS Soc. (2015) 18:20049. doi: 10.7448/IAS.18.1.20049 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.UNAIDS. UNAIDS Global AIDS Update 2024: The Urgency of Now: AIDS at a Crossroads. Geneva: Stylus Publishing, LLC; (2024). [Google Scholar]
- 10.Free C, Phillips G, Galli L, Watson L, Felix L, Edwards P, et al. The effectiveness of mobile-health technology-based health behaviour change or disease management interventions for health care consumers: a systematic review. PLoS Med. (2013) 10:e1001362. doi: 10.1371/journal.pmed.1001362 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Finitsis DJ, Pellowski JA, Johnson BT. Text message intervention designs to promote adherence to antiretroviral therapy (ART): a meta-analysis of randomized controlled trials. PLoS ONE. (2014) 9:e88166. doi: 10.1371/journal.pone.0088166 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Horvath T, Azman H, Kennedy GE, Rutherford GW, Cochrane HIVAG. Mobile phone text messaging for promoting adherence to antiretroviral therapy in patients with HIV infection. Cochrane Database Syst Rev. (1996) 2012: CD009756. doi: 10.1002/14651858.CD009756 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Lester RT, Ritvo P, Mills EJ, Kariri A, Karanja S, Chung MH, et al. Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial. Lancet. (2010) 376:1838–45. doi: 10.1016/S0140-6736(10)61997-6 [DOI] [PubMed] [Google Scholar]
- 14.Maduka O, Tobin-West C. Adherence counseling and reminder text messages improve uptake of antiretroviral therapy in a tertiary hospital in Nigeria. Niger J Clin Pract. (2013) 16:302–8. doi: 10.4103/1119-3077.113451 [DOI] [PubMed] [Google Scholar]
- 15.Mbuagbaw L, Thabane L, Ongolo-Zogo P, Lester RT, Mills EJ, Smieja M, et al. The Cameroon mobile phone SMS (CAMPS) trial: a randomized trial of text messaging versus usual care for adherence to antiretroviral therapy. PLoS ONE. (2012) 7:e46909. doi: 10.1371/journal.pone.0046909 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Goldstein M, Archary M, Adong J, Haberer JE, Kuhns LM, Kurth A, et al. Systematic review of mHealth interventions for adolescent and young adult HIV prevention and the adolescent HIV continuum of care in low to middle income countries. AIDS Behav. (2023) 27:94–115. doi: 10.1007/s10461-022-03840-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Mehra N, Tunje A, Hallström IK, Jerene D. Effectiveness of mobile phone text message reminder interventions to improve adherence to antiretroviral therapy among adolescents living with HIV: a systematic review and meta-analysis. PLoS ONE. (2021) 16:e0254890. doi: 10.1371/journal.pone.0254890 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Chanie ES, Feleke DG, Emiru TD, Abuhay AG, Hailemeskel HS, Baye AA, et al. Viral load undetectable state and predictors among children and adolescents living with HIV in South Gondar, Ethiopia, 2023: an 8-year retrospective cohort study. BMJ Open. (2024) 14:e083206. doi: 10.1136/bmjopen-2023-083206 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Tafere GW, Hunduma F, Yesuf A. Viral suppression rate at operation triple zero (Otz) and regular art follow-up programs and associated factors among adolescent clients of Addis Ababa Ethiopia: a comparative cross-sectional study. Virol J. (2023) 20:208. doi: 10.1186/s12985-023-02176-y [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.FMOH. Adolescent and Youth Engagement Guideline. (2016). Addis Ababa, Ethiopia. [Google Scholar]
- 21.Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. (2009) 42:377–81. doi: 10.1016/j.jbi.2008.08.010 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Jelsma J, Hansen K, De Weerdt W, De Cock P, Kind P. How do Zimbabweans value health states? Popul Health Metr. (2003) 1:11. doi: 10.1186/1478-7954-1-11 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Drummond MF, Sculpher MJ, Claxton K, Stoddart GL, Torrance GW. Methods for the Economic Evaluation of Health Care Programmes. Oxford: Oxford University Press; (2015). [Google Scholar]
- 24.Group TE. EuroQol-a new facility for the measurement of health-related quality of life. Health Policy. (1990) 16:199–208. doi: 10.1016/0168-8510(90)90421-9 [DOI] [PubMed] [Google Scholar]
- 25.Dolan P. Modeling valuations for EuroQol health states. Med Care. (1997) 35:1095–108. doi: 10.1097/00005650-199711000-00002 [DOI] [PubMed] [Google Scholar]
- 26.Ethiopia NBo. Exchange-rates. USD to ETB: Ethiopian Birr to U.S. Dollar Exchange-Rate History 2023. (2023). Addis Ababa, Ethiopia. [Google Scholar]
- 27.Ruggeri M, Silvia C, Paul MN. The minimum clinically important difference of the EQ-5D index. Expert Rev Pharmacoecon Outcomes Res. (2014) 14:221–233. doi: 10.1586/14737167.2014.894462 [DOI] [PubMed] [Google Scholar]
- 28.Shenderovich Y. Predictors and Consequences of HIV Status Disclosure to Adolescents Living with HIV in Eastern Cape, South Africa. (2021). Hoboken, NJ. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Devlin NJ, Brooks R. EQ-5D and the EuroQol group: past, present and future. Appl Health Econ Health Policy. (2017) 15:127–37. doi: 10.1007/s40258-017-0310-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Pop-Eleches C, Thirumurthy H, Habyarimana JP, Zivin JG, Goldstein MP, De Walque D, et al. Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: a randomized controlled trial of text message reminders. AIDS. (2011) 25:825–34. doi: 10.1097/QAD.0b013e32834380c1 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Kim MH, Mazenga AC, Yu X, Devandra A, Nguyen C, Ahmed S, et al. Factors associated with depression among adolescents living with HIV in Malawi. BMC Psychiatry. (2015) 15:264. doi: 10.1186/s12888-015-0649-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Degroote S, Vogelaers D, Vandijck DM. What determines health-related quality of life among people living with HIV: an updated review of the literature. Arch Public Health. (2014) 72:40. doi: 10.1186/2049-3258-72-40 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Peltzer K, Pengpid S. Socioeconomic factors in adherence to HIV therapy in low-and middle-income countries. J Health Popul Nutr. (2013) 31:150. doi: 10.3329/jhpn.v31i2.16379 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Cluver L, Shenderovich Y, Toska E, Rudgard WE, Zhou S, Orkin M, et al. Clinic and care: associations with adolescent antiretroviral therapy adherence in a prospective cohort in South Africa. AIDS. (2021) 35:1263–71. doi: 10.1097/QAD.0000000000002882 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Sherr L, Cluver L, Toska E, He E. Differing psychological vulnerabilities among behaviourally and perinatally HIV infected adolescents in South Africa–implications for targeted health service provision. AIDS Care. (2018) 30:92–101. doi: 10.1080/09540121.2018.1476664 [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.

